Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.
De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, Bonizzoni E, Topol EJ, Chiariello M. De Luca G, et al. Among authors: antoniucci d. J Am Coll Cardiol. 2006 Feb 7;47(3):685-6. doi: 10.1016/j.jacc.2005.11.018. Epub 2006 Jan 18. J Am Coll Cardiol. 2006. PMID: 16458158 Free article. No abstract available.
Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.
Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford BD, Antoniucci D, Krucoff MW, Gibbons RJ, Jones D, Lansky AJ, Mehran R; Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators. Stone GW, et al. Among authors: antoniucci d. JAMA. 2005 Mar 2;293(9):1063-72. doi: 10.1001/jama.293.9.1063. JAMA. 2005. PMID: 15741528 Clinical Trial.
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.
Kastrati A, Neumann FJ, Schulz S, Massberg S, Byrne RA, Ferenc M, Laugwitz KL, Pache J, Ott I, Hausleiter J, Seyfarth M, Gick M, Antoniucci D, Schömig A, Berger PB, Mehilli J; ISAR-REACT 4 Trial Investigators. Kastrati A, et al. Among authors: antoniucci d. N Engl J Med. 2011 Nov 24;365(21):1980-9. doi: 10.1056/NEJMoa1109596. Epub 2011 Nov 13. N Engl J Med. 2011. PMID: 22077909 Free article. Clinical Trial.
Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.
Parodi G, De Luca G, Moschi G, Bellandi B, Valenti R, Migliorini A, Carrabba N, Antoniucci D. Parodi G, et al. Among authors: antoniucci d. J Thromb Thrombolysis. 2010 Nov;30(4):446-51. doi: 10.1007/s11239-010-0481-5. J Thromb Thrombolysis. 2010. PMID: 20571920 Free PMC article.
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).
Brodie BR, Webb J, Cox DA, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford B, Antoniucci D, Stuckey T, Krucoff M, Gibbons R, Lansky A, Na Y, Mehran R, Stone GW; EMERALD Investigators. Brodie BR, et al. Among authors: antoniucci d. Am J Cardiol. 2007 Jun 15;99(12):1680-6. doi: 10.1016/j.amjcard.2007.01.047. Epub 2007 May 7. Am J Cardiol. 2007. PMID: 17560875 Clinical Trial.
300 results